NCT02238158View on ClinicalTrials.gov

Postmarketing Surveillance of Atrovent® in Chronic Obstructive Pulmonary Disease

CompletedOBSERVATIONAL
Enrollment

595

Participants

Timeline

Start Date

September 30, 1999

Primary Completion Date

April 30, 2001

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

Atrovent® inhalets

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02238158 - Postmarketing Surveillance of Atrovent® in Chronic Obstructive Pulmonary Disease | Biotech Hunter | Biotech Hunter